1987
DOI: 10.1016/0360-3016(87)90327-0
|View full text |Cite
|
Sign up to set email alerts
|

CT-assisted assessment of bladder and rectum dose in gynecological implants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
40
0

Year Published

1997
1997
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 123 publications
(43 citation statements)
references
References 21 publications
3
40
0
Order By: Relevance
“…However, these points are not the best surrogates. Many studies have reported inconsistencies between these points compared with volumetric image-based 3D dose calculation and they cannot be the best estimate to predict late complication to organs at risk (Ling et al, 1987;Schoeppel et al, 1993;Barillot et al, 1994;van der Bergh et al, 1998;Fellner et al, 2001;Jason et al, 2003;Kirisits et al, 2005;Pelloski et al, 2005;Tan et al, 2009;Vinod et al, 2011). Imagebased brachytherapy allows more conformal treatment, integrating the concepts of anatomy, tumour features, and tumour response with time.…”
Section: Discussionmentioning
confidence: 99%
“…However, these points are not the best surrogates. Many studies have reported inconsistencies between these points compared with volumetric image-based 3D dose calculation and they cannot be the best estimate to predict late complication to organs at risk (Ling et al, 1987;Schoeppel et al, 1993;Barillot et al, 1994;van der Bergh et al, 1998;Fellner et al, 2001;Jason et al, 2003;Kirisits et al, 2005;Pelloski et al, 2005;Tan et al, 2009;Vinod et al, 2011). Imagebased brachytherapy allows more conformal treatment, integrating the concepts of anatomy, tumour features, and tumour response with time.…”
Section: Discussionmentioning
confidence: 99%
“…Point dosing can also lead to excessive normal tissue toxicity, as with smaller tumors and smaller uteri in which predefined points may deliver dose into the bladder or rectum. Conventional International Commission on Radiation Units and Measurements (ICRU) points have been shown in several studies to underestimate maximum doses to the bladder and rectum (3,(5)(6)(7)(8)(9)(10)(11), and doses to these points have often failed to correlate with late toxicity (12). This may in part explain the relatively high rates of severe late gastrointestinal (GI) and genitourinary (GU) toxicity in the range of 5% to 10% reported in previous studies of conventional treatment techniques (13)(14)(15)(16).…”
Section: Introductionmentioning
confidence: 99%
“…Compared with the more recent 3D planning techniques, 2D planning generally overestimates the minimum dose delivered to the target volume and underestimates the maximum dose to the normal tissues. 12,[32][33][34] Consequently, reliable estimates of doses to the rectum for predicting the risk of LRC have not been established to date, and further larger scale studies and careful analyses of dose-volume histograms are required. However, the effectiveness of the absorbed dose at the RP, as defined by ICRU 38, has been demonstrated in other reports, with correlations between the dose estimates at the RP (BED RP ) and the risk of LRC being identified.…”
Section: Discussionmentioning
confidence: 99%